RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Frees Fund
F

Frees Fund portfolio

Frees Fund has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. It is a venture capital firm based in Beijing, CN, founded in 2015. Its most recent investment on record is Oricell Therapeutics's $70M Series B+ round in January 2026, alongside Qiming Venture Partners, Qatari sovereign wealth fund, NGS Super and 4 others. That company is in Health and bio.

Website: freesvc.com.
Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $70M.
Latest deal: Oricell Therapeutics · Jan 13, 2026.

About Frees Fund

Firm type: Venture capital.
Headquarters: Beijing, CN.
Founded: 2015.
Stages: Pre-Seed, Seed, Series A, Series B.
Sectors: AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Enterprise Software, Healthtech.
Check size: $425K to $35M.

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

What Frees Fund invests in

How Frees Fund invests

StageDealsCapital in rounds
Series B+ 1 100%$70M

Share is of the 1 round on Recent Funding that name Frees Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Frees Fund portfolio companies

CompanyRound with Frees FundTotal raisedLatest raise
OOricell Therapeutics
Health and bio
 Series B+ · $70M$235MApr 10, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Frees Fund, which is a subset of its real portfolio. API: /api/v1/investors/frees-fund (get a free API key). More: the most active VC firms and new venture capital funds.